Skip to main content
Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.05
+0.02 (0.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Kyntra Bio Revenue

In the year 2025, Kyntra Bio had annual revenue of $6.44M, down -78.26%. Kyntra Bio had revenue of $1.28M in the quarter ending December 31, 2025, a decrease of -59.27%.

Revenue (ttm)
$6.44M
Revenue Growth
-78.26%
P/S Ratio
4.43
Revenue / Employee
$189,412
Employees
34
Market Cap
28.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.44M-23.18M-78.26%
Dec 31, 202429.62M-17.18M-36.71%
Dec 31, 202346.80M-93.93M-66.74%
Dec 31, 2022140.73M-94.58M-40.19%
Dec 31, 2021235.31M58.99M33.46%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neuphoria Therapeutics 14.99M
Apollomics 8.99M
Dyadic International 3.09M
Longeveron 1.20M
Daré Bioscience 1.03M
Lisata Therapeutics 170.00K
Revenue Rankings

KYNB News

More News